Skip to main navigation Skip to search Skip to main content

A Phase III Randomized, Open-Label Study of CG1940 and CG8711 Versus Docetaxel and Estramustine in Patients with Metastatic Hormone-Refractory Prostate Cancer who are Chemotherapy-Naive

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date11/19/04 → 11/30/09

Funding

  • Cell Genesys Incorporated: $37,210.00